Splicing	B:C0035687
variants	O
of	O
ADAR2	O
and	O
ADAR2	O
-	O
mediated	O
RNA	O
editing	I:C0162782
in	O
glioma	O
.	O

Splicing	O
variants	O
of	O
ADAR2	B:C0001457
and	O
ADAR2	O
-	O
mediated	O
RNA	O
editing	I:C0162782
in	O
glioma	O
.	O

Splicing	O
variants	O
of	O
ADAR2	O
and	O
ADAR2	B:C0001457
-	O
mediated	O
RNA	O
editing	I:C0162782
in	O
glioma	O
.	O

Splicing	O
variants	O
of	O
ADAR2	O
and	O
ADAR2	O
-	O
mediated	O
RNA	B:C0162782
editing	I:C0162782
in	O
glioma	O
.	O

Splicing	O
variants	O
of	O
ADAR2	O
and	O
ADAR2	O
-	O
mediated	O
RNA	O
editing	I:C0162782
in	O
glioma	B:C0017638
.	O

The	O
roles	O
of	O
alternative	B:C0002345
splicing	I:C0002345
and	O
RNA	O
editing	I:C0162782
in	O
gene	O
regulation	I:C0017263
and	O
transcriptome	O
diversity	O
are	O
well	O
documented	O
.	O

The	O
roles	O
of	O
alternative	O
splicing	I:C0002345
and	O
RNA	B:C0162782
editing	I:C0162782
in	O
gene	O
regulation	I:C0017263
and	O
transcriptome	O
diversity	O
are	O
well	O
documented	O
.	O

The	O
roles	O
of	O
alternative	O
splicing	I:C0002345
and	O
RNA	O
editing	I:C0162782
in	O
gene	B:C0017263
regulation	I:C0017263
and	O
transcriptome	O
diversity	O
are	O
well	O
documented	O
.	O

The	O
roles	O
of	O
alternative	O
splicing	I:C0002345
and	O
RNA	O
editing	I:C0162782
in	O
gene	O
regulation	I:C0017263
and	O
transcriptome	B:C3178810
diversity	O
are	O
well	O
documented	O
.	O

Adenosine	B:C0001457
deaminases	I:C0001457
acting	O
on	O
RNA	O
(	O
ADARs	O
)	O
are	O
responsible	O
for	O
adenosine	O
-	I:C1158747
to	I:C1158747
-	I:C1158747
inosine	I:C1158747
(	I:C1158747
A	I:C1158747
-	I:C1158747
to	I:C1158747
-	I:C1158747
I	I:C1158747
)	I:C1158747
editing	I:C1158747
and	O
exemplify	O
the	O
complex	O
association	O
between	O
RNA	O
editing	I:C0162782
and	O
alternative	O
splicing	I:C0002345
.	O

Adenosine	O
deaminases	I:C0001457
acting	O
on	O
RNA	B:C0035668
(	O
ADARs	O
)	O
are	O
responsible	O
for	O
adenosine	O
-	I:C1158747
to	I:C1158747
-	I:C1158747
inosine	I:C1158747
(	I:C1158747
A	I:C1158747
-	I:C1158747
to	I:C1158747
-	I:C1158747
I	I:C1158747
)	I:C1158747
editing	I:C1158747
and	O
exemplify	O
the	O
complex	O
association	O
between	O
RNA	O
editing	I:C0162782
and	O
alternative	O
splicing	I:C0002345
.	O

Adenosine	O
deaminases	I:C0001457
acting	O
on	O
RNA	O
(	O
ADARs	B:C0001457
)	O
are	O
responsible	O
for	O
adenosine	O
-	I:C1158747
to	I:C1158747
-	I:C1158747
inosine	I:C1158747
(	I:C1158747
A	I:C1158747
-	I:C1158747
to	I:C1158747
-	I:C1158747
I	I:C1158747
)	I:C1158747
editing	I:C1158747
and	O
exemplify	O
the	O
complex	O
association	O
between	O
RNA	O
editing	I:C0162782
and	O
alternative	O
splicing	I:C0002345
.	O

Adenosine	O
deaminases	I:C0001457
acting	O
on	O
RNA	O
(	O
ADARs	O
)	O
are	O
responsible	O
for	O
adenosine	B:C1158747
-	I:C1158747
to	I:C1158747
-	I:C1158747
inosine	I:C1158747
(	I:C1158747
A	I:C1158747
-	I:C1158747
to	I:C1158747
-	I:C1158747
I	I:C1158747
)	I:C1158747
editing	I:C1158747
and	O
exemplify	O
the	O
complex	O
association	O
between	O
RNA	O
editing	I:C0162782
and	O
alternative	O
splicing	I:C0002345
.	O

Adenosine	O
deaminases	I:C0001457
acting	O
on	O
RNA	O
(	O
ADARs	O
)	O
are	O
responsible	O
for	O
adenosine	O
-	I:C1158747
to	I:C1158747
-	I:C1158747
inosine	I:C1158747
(	I:C1158747
A	I:C1158747
-	I:C1158747
to	I:C1158747
-	I:C1158747
I	I:C1158747
)	I:C1158747
editing	I:C1158747
and	O
exemplify	O
the	O
complex	O
association	O
between	O
RNA	B:C0162782
editing	I:C0162782
and	O
alternative	O
splicing	I:C0002345
.	O

Adenosine	O
deaminases	I:C0001457
acting	O
on	O
RNA	O
(	O
ADARs	O
)	O
are	O
responsible	O
for	O
adenosine	O
-	I:C1158747
to	I:C1158747
-	I:C1158747
inosine	I:C1158747
(	I:C1158747
A	I:C1158747
-	I:C1158747
to	I:C1158747
-	I:C1158747
I	I:C1158747
)	I:C1158747
editing	I:C1158747
and	O
exemplify	O
the	O
complex	O
association	O
between	O
RNA	O
editing	I:C0162782
and	O
alternative	B:C0002345
splicing	I:C0002345
.	O

The	O
self	B:C0162782
-	I:C0162782
editing	I:C0162782
activity	O
of	O
ADAR2	O
,	O
which	O
acts	O
on	O
its	O
own	O
pre-mRNA	O
,	O
leads	O
to	O
its	O
alternative	O
splicing	I:C0002345
.	O

The	O
self	O
-	I:C0162782
editing	I:C0162782
activity	O
of	O
ADAR2	B:C0001457
,	O
which	O
acts	O
on	O
its	O
own	O
pre-mRNA	O
,	O
leads	O
to	O
its	O
alternative	O
splicing	I:C0002345
.	O

The	O
self	O
-	I:C0162782
editing	I:C0162782
activity	O
of	O
ADAR2	O
,	O
which	O
acts	O
on	O
its	O
own	O
pre-mRNA	B:C0026661
,	O
leads	O
to	O
its	O
alternative	O
splicing	I:C0002345
.	O

The	O
self	O
-	I:C0162782
editing	I:C0162782
activity	O
of	O
ADAR2	O
,	O
which	O
acts	O
on	O
its	O
own	O
pre-mRNA	O
,	O
leads	O
to	O
its	O
alternative	B:C0002345
splicing	I:C0002345
.	O

Alternative	B:C0002345
splicing	I:C0002345
occurs	O
independently	O
at	O
nine	O
splicing	O
sites	O
on	O
ADAR2	O
pre-mRNA	O
,	O
generating	O
numerous	O
alternative	O
splicing	I:C0002345
variants	O
with	O
various	O
catalytic	O
activities	I:C0243102
.	O

Alternative	O
splicing	I:C0002345
occurs	O
independently	O
at	O
nine	O
splicing	B:C0035687
sites	O
on	O
ADAR2	O
pre-mRNA	O
,	O
generating	O
numerous	O
alternative	O
splicing	I:C0002345
variants	O
with	O
various	O
catalytic	O
activities	I:C0243102
.	O

Alternative	O
splicing	I:C0002345
occurs	O
independently	O
at	O
nine	O
splicing	O
sites	O
on	O
ADAR2	B:C0001457
pre-mRNA	O
,	O
generating	O
numerous	O
alternative	O
splicing	I:C0002345
variants	O
with	O
various	O
catalytic	O
activities	I:C0243102
.	O

Alternative	O
splicing	I:C0002345
occurs	O
independently	O
at	O
nine	O
splicing	O
sites	O
on	O
ADAR2	O
pre-mRNA	B:C0026661
,	O
generating	O
numerous	O
alternative	O
splicing	I:C0002345
variants	O
with	O
various	O
catalytic	O
activities	I:C0243102
.	O

Alternative	O
splicing	I:C0002345
occurs	O
independently	O
at	O
nine	O
splicing	O
sites	O
on	O
ADAR2	O
pre-mRNA	O
,	O
generating	O
numerous	O
alternative	B:C0002345
splicing	I:C0002345
variants	O
with	O
various	O
catalytic	O
activities	I:C0243102
.	O

Alternative	O
splicing	I:C0002345
occurs	O
independently	O
at	O
nine	O
splicing	O
sites	O
on	O
ADAR2	O
pre-mRNA	O
,	O
generating	O
numerous	O
alternative	O
splicing	I:C0002345
variants	O
with	O
various	O
catalytic	B:C0243102
activities	I:C0243102
.	O

A	B:C1158747
-	I:C1158747
to	I:C1158747
-	I:C1158747
I	I:C1158747
RNA	I:C1158747
editing	I:C1158747
is	O
important	O
in	O
a	O
range	O
of	O
physiological	O
processes	I:C0031845
in	O
humans	O
and	O
is	O
associated	O
with	O
several	O
diseases	O
,	O
including	O
amyotrophic	O
lateral	I:C0002736
sclerosis	I:C0002736
,	O
mood	O
disorders	I:C0525045
,	O
epilepsy	O
and	O
glioma	O
.	O

A	O
-	I:C1158747
to	I:C1158747
-	I:C1158747
I	I:C1158747
RNA	I:C1158747
editing	I:C1158747
is	O
important	O
in	O
a	O
range	O
of	O
physiological	B:C0031845
processes	I:C0031845
in	O
humans	O
and	O
is	O
associated	O
with	O
several	O
diseases	O
,	O
including	O
amyotrophic	O
lateral	I:C0002736
sclerosis	I:C0002736
,	O
mood	O
disorders	I:C0525045
,	O
epilepsy	O
and	O
glioma	O
.	O

A	O
-	I:C1158747
to	I:C1158747
-	I:C1158747
I	I:C1158747
RNA	I:C1158747
editing	I:C1158747
is	O
important	O
in	O
a	O
range	O
of	O
physiological	O
processes	I:C0031845
in	O
humans	B:C0086418
and	O
is	O
associated	O
with	O
several	O
diseases	O
,	O
including	O
amyotrophic	O
lateral	I:C0002736
sclerosis	I:C0002736
,	O
mood	O
disorders	I:C0525045
,	O
epilepsy	O
and	O
glioma	O
.	O

A	O
-	I:C1158747
to	I:C1158747
-	I:C1158747
I	I:C1158747
RNA	I:C1158747
editing	I:C1158747
is	O
important	O
in	O
a	O
range	O
of	O
physiological	O
processes	I:C0031845
in	O
humans	O
and	O
is	O
associated	O
with	O
several	O
diseases	B:C0012634
,	O
including	O
amyotrophic	O
lateral	I:C0002736
sclerosis	I:C0002736
,	O
mood	O
disorders	I:C0525045
,	O
epilepsy	O
and	O
glioma	O
.	O

A	O
-	I:C1158747
to	I:C1158747
-	I:C1158747
I	I:C1158747
RNA	I:C1158747
editing	I:C1158747
is	O
important	O
in	O
a	O
range	O
of	O
physiological	O
processes	I:C0031845
in	O
humans	O
and	O
is	O
associated	O
with	O
several	O
diseases	O
,	O
including	O
amyotrophic	B:C0002736
lateral	I:C0002736
sclerosis	I:C0002736
,	O
mood	O
disorders	I:C0525045
,	O
epilepsy	O
and	O
glioma	O
.	O

A	O
-	I:C1158747
to	I:C1158747
-	I:C1158747
I	I:C1158747
RNA	I:C1158747
editing	I:C1158747
is	O
important	O
in	O
a	O
range	O
of	O
physiological	O
processes	I:C0031845
in	O
humans	O
and	O
is	O
associated	O
with	O
several	O
diseases	O
,	O
including	O
amyotrophic	O
lateral	I:C0002736
sclerosis	I:C0002736
,	O
mood	B:C0525045
disorders	I:C0525045
,	O
epilepsy	O
and	O
glioma	O
.	O

A	O
-	I:C1158747
to	I:C1158747
-	I:C1158747
I	I:C1158747
RNA	I:C1158747
editing	I:C1158747
is	O
important	O
in	O
a	O
range	O
of	O
physiological	O
processes	I:C0031845
in	O
humans	O
and	O
is	O
associated	O
with	O
several	O
diseases	O
,	O
including	O
amyotrophic	O
lateral	I:C0002736
sclerosis	I:C0002736
,	O
mood	O
disorders	I:C0525045
,	O
epilepsy	B:C0014544
and	O
glioma	O
.	O

A	O
-	I:C1158747
to	I:C1158747
-	I:C1158747
I	I:C1158747
RNA	I:C1158747
editing	I:C1158747
is	O
important	O
in	O
a	O
range	O
of	O
physiological	O
processes	I:C0031845
in	O
humans	O
and	O
is	O
associated	O
with	O
several	O
diseases	O
,	O
including	O
amyotrophic	O
lateral	I:C0002736
sclerosis	I:C0002736
,	O
mood	O
disorders	I:C0525045
,	O
epilepsy	O
and	O
glioma	B:C0017638
.	O

Reduced	O
editing	B:C0162782
at	O
the	O
glutamine	O
/	O
arginine	O
site	O
of	O
the	O
AMPA	O
receptor	I:C0536483
subunit	I:C0536483
GluA2	I:C0536483
in	O
glioma	O
,	O
without	O
any	O
alteration	O
in	O
ADAR2	O
expression	O
,	O
is	O
a	O
notable	O
phenomenon	O
.	O

Reduced	O
editing	O
at	O
the	O
glutamine	B:C0017797
/	O
arginine	O
site	O
of	O
the	O
AMPA	O
receptor	I:C0536483
subunit	I:C0536483
GluA2	I:C0536483
in	O
glioma	O
,	O
without	O
any	O
alteration	O
in	O
ADAR2	O
expression	O
,	O
is	O
a	O
notable	O
phenomenon	O
.	O

Reduced	O
editing	O
at	O
the	O
glutamine	O
/	O
arginine	B:C0003765
site	O
of	O
the	O
AMPA	O
receptor	I:C0536483
subunit	I:C0536483
GluA2	I:C0536483
in	O
glioma	O
,	O
without	O
any	O
alteration	O
in	O
ADAR2	O
expression	O
,	O
is	O
a	O
notable	O
phenomenon	O
.	O

Reduced	O
editing	O
at	O
the	O
glutamine	O
/	O
arginine	O
site	O
of	O
the	O
AMPA	B:C0536483
receptor	I:C0536483
subunit	I:C0536483
GluA2	I:C0536483
in	O
glioma	O
,	O
without	O
any	O
alteration	O
in	O
ADAR2	O
expression	O
,	O
is	O
a	O
notable	O
phenomenon	O
.	O

Reduced	O
editing	O
at	O
the	O
glutamine	O
/	O
arginine	O
site	O
of	O
the	O
AMPA	O
receptor	I:C0536483
subunit	I:C0536483
GluA2	I:C0536483
in	O
glioma	B:C0017638
,	O
without	O
any	O
alteration	O
in	O
ADAR2	O
expression	O
,	O
is	O
a	O
notable	O
phenomenon	O
.	O

Reduced	O
editing	O
at	O
the	O
glutamine	O
/	O
arginine	O
site	O
of	O
the	O
AMPA	O
receptor	I:C0536483
subunit	I:C0536483
GluA2	I:C0536483
in	O
glioma	O
,	O
without	O
any	O
alteration	O
in	O
ADAR2	B:C0001457
expression	O
,	O
is	O
a	O
notable	O
phenomenon	O
.	O

Reduced	O
editing	O
at	O
the	O
glutamine	O
/	O
arginine	O
site	O
of	O
the	O
AMPA	O
receptor	I:C0536483
subunit	I:C0536483
GluA2	I:C0536483
in	O
glioma	O
,	O
without	O
any	O
alteration	O
in	O
ADAR2	O
expression	B:C1171362
,	O
is	O
a	O
notable	O
phenomenon	O
.	O

Several	O
studies	O
have	O
tried	O
to	O
explain	O
this	O
alteration	O
in	O
the	O
catalytic	B:C0243102
activity	I:C0243102
of	O
ADAR2	O
;	O
however	O
,	O
the	O
underlying	O
mechanism	O
remains	O
unclear	O
.	O

Several	O
studies	O
have	O
tried	O
to	O
explain	O
this	O
alteration	O
in	O
the	O
catalytic	O
activity	I:C0243102
of	O
ADAR2	B:C0001457
;	O
however	O
,	O
the	O
underlying	O
mechanism	O
remains	O
unclear	O
.	O

The	O
present	O
review	B:C0282443
summarizes	O
the	O
relevant	O
literature	O
and	O
shares	O
experimental	O
results	I:C2825142
concerning	O
ADAR2	O
alternative	O
splicing	I:C0002345
.	O

The	O
present	O
review	O
summarizes	O
the	O
relevant	O
literature	B:C0023866
and	O
shares	O
experimental	O
results	I:C2825142
concerning	O
ADAR2	O
alternative	O
splicing	I:C0002345
.	O

The	O
present	O
review	O
summarizes	O
the	O
relevant	O
literature	O
and	O
shares	O
experimental	B:C2825142
results	I:C2825142
concerning	O
ADAR2	O
alternative	O
splicing	I:C0002345
.	O

The	O
present	O
review	O
summarizes	O
the	O
relevant	O
literature	O
and	O
shares	O
experimental	O
results	I:C2825142
concerning	O
ADAR2	B:C0001457
alternative	O
splicing	I:C0002345
.	O

The	O
present	O
review	O
summarizes	O
the	O
relevant	O
literature	O
and	O
shares	O
experimental	O
results	I:C2825142
concerning	O
ADAR2	O
alternative	B:C0002345
splicing	I:C0002345
.	O

In	O
particular	O
,	O
the	O
present	O
review	B:C0282443
demonstrates	O
that	O
shifts	O
in	O
the	O
relative	O
abundance	O
of	O
the	O
active	O
and	O
inactive	O
splicing	O
variants	O
of	O
ADAR2	O
may	O
reduce	O
the	O
ADAR2	O
editing	O
activity	O
in	O
glioma	O
.	O

In	O
particular	O
,	O
the	O
present	O
review	O
demonstrates	O
that	O
shifts	O
in	O
the	O
relative	O
abundance	O
of	O
the	O
active	O
and	O
inactive	O
splicing	B:C0035687
variants	O
of	O
ADAR2	O
may	O
reduce	O
the	O
ADAR2	O
editing	O
activity	O
in	O
glioma	O
.	O

In	O
particular	O
,	O
the	O
present	O
review	O
demonstrates	O
that	O
shifts	O
in	O
the	O
relative	O
abundance	O
of	O
the	O
active	O
and	O
inactive	O
splicing	O
variants	O
of	O
ADAR2	B:C0001457
may	O
reduce	O
the	O
ADAR2	O
editing	O
activity	O
in	O
glioma	O
.	O

In	O
particular	O
,	O
the	O
present	O
review	O
demonstrates	O
that	O
shifts	O
in	O
the	O
relative	O
abundance	O
of	O
the	O
active	O
and	O
inactive	O
splicing	O
variants	O
of	O
ADAR2	O
may	O
reduce	O
the	O
ADAR2	B:C0001457
editing	O
activity	O
in	O
glioma	O
.	O

In	O
particular	O
,	O
the	O
present	O
review	O
demonstrates	O
that	O
shifts	O
in	O
the	O
relative	O
abundance	O
of	O
the	O
active	O
and	O
inactive	O
splicing	O
variants	O
of	O
ADAR2	O
may	O
reduce	O
the	O
ADAR2	O
editing	B:C0162782
activity	O
in	O
glioma	O
.	O

In	O
particular	O
,	O
the	O
present	O
review	O
demonstrates	O
that	O
shifts	O
in	O
the	O
relative	O
abundance	O
of	O
the	O
active	O
and	O
inactive	O
splicing	O
variants	O
of	O
ADAR2	O
may	O
reduce	O
the	O
ADAR2	O
editing	O
activity	O
in	O
glioma	B:C0017638
.	O

Dominant	O
expression	B:C1171362
of	O
ADAR2	O
splicing	O
variant	O
with	O
low	O
enzyme	O
activity	I:C0243102
causes	O
reduced	O
RNA	O
editing	I:C0162782
of	O
GluA2	O
subunit	I:C0536483
at	O
the	O
glutamine	O
/	O
arginine	O
site	O
in	O
glioma	O
.	O

Dominant	O
expression	O
of	O
ADAR2	B:C0001457
splicing	O
variant	O
with	O
low	O
enzyme	O
activity	I:C0243102
causes	O
reduced	O
RNA	O
editing	I:C0162782
of	O
GluA2	O
subunit	I:C0536483
at	O
the	O
glutamine	O
/	O
arginine	O
site	O
in	O
glioma	O
.	O

Dominant	O
expression	O
of	O
ADAR2	O
splicing	B:C0035687
variant	O
with	O
low	O
enzyme	O
activity	I:C0243102
causes	O
reduced	O
RNA	O
editing	I:C0162782
of	O
GluA2	O
subunit	I:C0536483
at	O
the	O
glutamine	O
/	O
arginine	O
site	O
in	O
glioma	O
.	O

Dominant	O
expression	O
of	O
ADAR2	O
splicing	O
variant	O
with	O
low	O
enzyme	B:C0243102
activity	I:C0243102
causes	O
reduced	O
RNA	O
editing	I:C0162782
of	O
GluA2	O
subunit	I:C0536483
at	O
the	O
glutamine	O
/	O
arginine	O
site	O
in	O
glioma	O
.	O

Dominant	O
expression	O
of	O
ADAR2	O
splicing	O
variant	O
with	O
low	O
enzyme	O
activity	I:C0243102
causes	O
reduced	O
RNA	B:C0162782
editing	I:C0162782
of	O
GluA2	O
subunit	I:C0536483
at	O
the	O
glutamine	O
/	O
arginine	O
site	O
in	O
glioma	O
.	O

Dominant	O
expression	O
of	O
ADAR2	O
splicing	O
variant	O
with	O
low	O
enzyme	O
activity	I:C0243102
causes	O
reduced	O
RNA	O
editing	I:C0162782
of	O
GluA2	B:C0536483
subunit	I:C0536483
at	O
the	O
glutamine	O
/	O
arginine	O
site	O
in	O
glioma	O
.	O

Dominant	O
expression	O
of	O
ADAR2	O
splicing	O
variant	O
with	O
low	O
enzyme	O
activity	I:C0243102
causes	O
reduced	O
RNA	O
editing	I:C0162782
of	O
GluA2	O
subunit	I:C0536483
at	O
the	O
glutamine	B:C0017797
/	O
arginine	O
site	O
in	O
glioma	O
.	O

Dominant	O
expression	O
of	O
ADAR2	O
splicing	O
variant	O
with	O
low	O
enzyme	O
activity	I:C0243102
causes	O
reduced	O
RNA	O
editing	I:C0162782
of	O
GluA2	O
subunit	I:C0536483
at	O
the	O
glutamine	O
/	O
arginine	B:C0003765
site	O
in	O
glioma	O
.	O

Dominant	O
expression	O
of	O
ADAR2	O
splicing	O
variant	O
with	O
low	O
enzyme	O
activity	I:C0243102
causes	O
reduced	O
RNA	O
editing	I:C0162782
of	O
GluA2	O
subunit	I:C0536483
at	O
the	O
glutamine	O
/	O
arginine	O
site	O
in	O
glioma	B:C0017638
.	O

